Tag: opioid legislation

Opioid REMS Update 2013

When we last covered the topic of the FDA’s intended plans for curbing opioid risk, we felt confident that one thing was for sure – education would likely be a key ingredient of the ultimate implemented solution. As it turns out, our assumption was correct. As we mentioned in our opioid REMS update 2012, on Tuesday, April… Read more »

FDA Announces New Safety Measures for Extended-Release and Long-Acting Opioids

On September 10, 2013, the Food and Drug Administration (FDA) announced a number of changes that are intended to increase the safety of extended-release and long-acting (ER/LA) opioid medications. This announcement applies to all currently marketed ER/LA opioids, and implements two specific approaches to achieve the goal of combatting “the crisis of misuse, abuse, addiction, overdose, and death” according… Read more »

Opioid REMS Becomes a Reality

When PainEDU.org last covered the topic of the Food and Drug Administration (FDA’s) intended plans for curbing opioid risk, we felt confident one thing was for sure – that education would likely be a key ingredient in the ultimate implemented solution. On Tuesday, April 19th, 2011, a press conference was held to announce the White House’s National Prescription… Read more »